Replimune Group, Inc. — Director's Dealing 2020

Nov 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2020-11-02

Reporting Person: Lewis Tanya (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-02	Stock Option (right to buy)	$42.00	A	33000	Acquired	2030-11-02	Common Stock (33000)	Direct

Footnotes

F1: 25% of the shares underlying this stock option vest on November 2, 2021, and the remainder of the shares underlying this stock option vest in 24 approximately equal monthly installments thereafter.